Your browser doesn't support javascript.
loading
Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models.
Harris, Emily M; Strope, Jonathan D; Beedie, Shaunna L; Huang, Phoebe A; Goey, Andrew K L; Cook, Kristina M; Schofield, Christopher J; Chau, Cindy H; Cadelis, Melissa M; Copp, Brent R; Gustafson, Kirk R; Figg, William D.
Afiliação
  • Harris EM; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. emily.harris5050@gmail.com.
  • Strope JD; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. jonathan.strope@nih.gov.
  • Beedie SL; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. shaunna.beedie@oncology.ox.ac.uk.
  • Huang PA; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. phoebe.huang@nih.gov.
  • Goey AKL; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. andrewgoey@hotmail.com.
  • Cook KM; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. kristina.cook@sydney.edu.au.
  • Schofield CJ; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford OX1 5JJ, UK. christopher.schofield@chem.ox.ac.uk.
  • Chau CH; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. chauc@mail.nih.gov.
  • Cadelis MM; School of Chemical Sciences, University of Auckland, Auckland 1142, New Zealand. m.cadelis@auckland.ac.nz.
  • Copp BR; School of Chemical Sciences, University of Auckland, Auckland 1142, New Zealand. b.copp@auckland.ac.nz.
  • Gustafson KR; Molecular Targets Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA. gustafki@mail.nih.gov.
  • Figg WD; Molecular Pharmacology Section, Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. figgw@mail.nih.gov.
Mar Drugs ; 16(7)2018 Jul 19.
Article em En | MEDLINE | ID: mdl-30029505
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinonas / Inibidores da Angiogênese / Compostos Heterocíclicos de 4 ou mais Anéis / Neovascularização Patológica / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Mar Drugs Assunto da revista: BIOLOGIA / FARMACOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinonas / Inibidores da Angiogênese / Compostos Heterocíclicos de 4 ou mais Anéis / Neovascularização Patológica / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Mar Drugs Assunto da revista: BIOLOGIA / FARMACOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos